The dose-dependent pharmacokinetics of N,N'-dicyclo-propyl -methyl-pip
erazine-dichlorhydrate (Ino 2628 CZ, CAS 82909-97-5), a new inotropic
compound, was studied after 4 intravenous infusions in 3 subjects and
4 orally administered doses in 6 subjects. Plasma and urine levels wer
e determined over 72 h. The results show that the pharmacokinetics of
Ino 2628 CZ was dose proportional over the intravenous and oral dose r
ange of 100 to 400 mg.